Published DateClear

Start Date

End Date

Category

• Pipeline2

Organizations

• Bausch + Lomb66
• Eyes On Eyecare51
• Alcon, Inc.45
• American Optometric Association37
• Harrow29
• Glaukos27
• Topcon Healthcare25
• Regeneron24
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• FDA2
• Clinical Trials2
• Eye Drop Solution2
• Eye Drops2
• Presbyopia1
• Presbyopia Eye Drops1

• Organizations: Cloudbreak Pharma✕

Clear all

Pipeline

FDA clears Cloudbreak Pharma's IND for phase 2 presbyopia drop trials

Clearance green lights advancement of CBT-199, an ophthalmic emulsion with a proprietary, water-free formulation and parasympathomimetic miotic agent.

Pipeline

Cloudbreak advances vascularized pinguecula eye drop to phase 3 trials

Company’s investigational multi-kinase inhibitor targeting VEGFs and PD-GFRs met phase 2 primary endpoint of conjunctival hyperemia earlier this year